labetalol has been researched along with Arrhythmias, Cardiac in 16 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol, a drug with alpha- and beta-adrenergic receptor blocking effects, was used to attenuate hypertension and tachycardia associated with electroconvulsive therapy (ECT) in a series of 11 elderly patients with refractory depression and cardiovascular disease in a placebo-controlled, double-blind crossover study design." | 5.06 | Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients. ( Cooper, R; Gladson, M; Knos, G; Markwalter, H; Morris, R; Stoudemire, A; Sung, YF, 1990) |
| "Cocaine body packing may expose to the risk of intestinal obstruction or acute cocaine poisoning." | 3.72 | [Surgery to save body-packers]. ( Baud, F; Couchard, AC; Ekhérian, JM; Goldgran-Tolédano, D; Mégarbane, B, 2004) |
| "Ventricular arrhythmias are common in patients with mitral valve prolapse." | 2.66 | Management of ventricular arrhythmias associated with mitral valve prolapse by combined alpha and beta blockade. ( Banim, SO; Butrous, GS; Camm, AJ; Maltz, MB; O'Keefe, J, 1986) |
| "Moxonidine has been shown to be antiarrhythmic during ischaemia in vivo." | 1.30 | Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model. ( Cobbe, SM; Hicks, MN; Kane, KA; Wolk, R, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Mégarbane, B | 1 |
| Ekhérian, JM | 1 |
| Couchard, AC | 1 |
| Goldgran-Tolédano, D | 1 |
| Baud, F | 1 |
| Johns, VJ | 1 |
| Forbes, R | 1 |
| Clanachan, AS | 1 |
| Moonie, GT | 1 |
| Pogwizd, SM | 1 |
| Sharma, AD | 1 |
| Corr, PB | 1 |
| Stoudemire, A | 2 |
| Trejo Gabriel y Galán, JM | 1 |
| Wolk, R | 1 |
| Kane, KA | 1 |
| Cobbe, SM | 1 |
| Hicks, MN | 1 |
| Pickard, T | 1 |
| Frishman, W | 1 |
| Halprin, S | 1 |
| Connor, H | 1 |
| Hine, IP | 1 |
| Hart, DG | 1 |
| Knos, G | 1 |
| Gladson, M | 1 |
| Markwalter, H | 1 |
| Sung, YF | 1 |
| Morris, R | 1 |
| Cooper, R | 1 |
| Karch, SB | 1 |
| Roelofse, JA | 1 |
| Shipton, EA | 1 |
| de V Joubert, JJ | 1 |
| Luus, HG | 1 |
| Butrous, GS | 1 |
| Maltz, MB | 1 |
| O'Keefe, J | 1 |
| Banim, SO | 1 |
| Camm, AJ | 1 |
| Valenta, LJ | 1 |
| Kern, J | 1 |
2 reviews available for labetalol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Beta-blocking drugs for arrhythmias, hypertension, and ischemic heart disease.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Atenolol; Blood Pressur | 1984 |
[Treatment of medical complications: hypertension/hypotension, hyperglycemia, hyperthermia, hypoxia, cardiac complications and pulmonary embolism].
Topics: Administration, Oral; Antihypertensive Agents; Arrhythmias, Cardiac; Cerebrovascular Disorders; Hear | 1995 |
3 trials available for labetalol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol.
Topics: Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Coronary Disease; Eth | 1979 |
Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients.
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Diseases; Depressive Disorder; Double-Bli | 1990 |
Management of ventricular arrhythmias associated with mitral valve prolapse by combined alpha and beta blockade.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Exercise Test; Female; Humans; Isometric Con | 1986 |
11 other studies available for labetalol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
[Surgery to save body-packers].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Arrhythmias, Cardiac; Cocaine; Diges | 2004 |
Adrenaline induced dysrhythmias: comparison of the antidysrhythmic effect of labetalol with propranolol during normocarbia and hypercarbia in halothane anaesthetized cats.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbon Dioxide; Cats; Epinephrine | 1980 |
Influences of labetalol a combined alpha- and beta-adrenergic blocking agent on the dysrhythmias induced by coronary occlusion and reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Cats; Coronary Disease; Disease Models, Animal; Dose-Response Relatio | 1982 |
Cardiovascular morbidity and ECT.
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Drug Therapy, Combi | 1995 |
Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model.
Topics: Action Potentials; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Disease Models, Animal; E | 1999 |
Getting past the obvious in an ED case of altered mental status and ECG changes.
Topics: Antihypertensive Agents; Arrhythmias, Cardiac; Diagnosis, Differential; Electrocardiography; Emergen | 2000 |
Labetalol in severe tetanus.
Topics: Aged; Arrhythmias, Cardiac; Ethanolamines; Female; Humans; Infusions, Parenteral; Labetalol; Tetanus | 1979 |
Managing cocaine crisis.
Topics: Arrhythmias, Cardiac; Cocaine; Diazepam; Humans; Hypertension; Labetalol; Seizures; Substance-Relate | 1989 |
The cardiovascular response to tracheal intubation during anaesthesia for oral surgical procedures. Effects of labetalol, acebutolol and lignocaine on cardiac rhythm.
Topics: Acebutolol; Adult; Anesthesia, Dental; Anesthesia, Intravenous; Arrhythmias, Cardiac; Female; Heart | 1986 |
Labetalol for hypertension.
Topics: Aged; Arrhythmias, Cardiac; Ethanolamines; Female; Humans; Hypertension; Hypotension; Labetalol; Mal | 1985 |